Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3

Nature Genetics

Volumn 43, Issue 1, 2011, Pages 55-59

  Chen, Zi Jiang ^a,b   Zhao, Han ^a,b   He, Lin ^c,d,e   Shi, Yuhua ^a,b   Qin, Yingying ^a,b   Shi, Yongyong ^d   Li, Zhiqiang ^d   You, Li ^a,b   Zhao, Junli ^f   Liu, Jiayin ^g   Liang, Xiaoyan ^h   Zhao, Xiaoming ⁱ   Zhao, Junzhao ^j   Sun, Yingpu ^k   Zhang, Bo ^l   Jiang, Hong ^m   Zhao, Dongni ⁿ   Bian, Yuehong ^a,b   Gao, Xuan ^a,b   Geng, Ling ^a,b   Li, Yiran ^o,p   Zhu, Dongyi ^q   Sun, Xiuqin ^r   Xu, Jin E ^s   Hao, Cuifang ^t   Ren, Chun E ^p   Zhang, Yajie ^u   Chen, Shiling ^v   Zhang, Wei ^c   Yang, Aijun ^w   Yan, Junhao ^a,b   Li, Yuan ^a,b   Ma, Jinlong ^a,b   Zhao, Yueran ^a,b   more..

^a SHANDONG UNIVERSITY   (China)

^b Shandong Provincial Key Laboratory of Computer Network   (China)

^c FUDAN UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^f NINGXIA MEDICAL UNIVERSITY   (China)

^g NANJING MEDICAL UNIVERSITY   (China)

^h SUN YAT SEN UNIVERSITY   (China)

ⁱ SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^j WENZHOU MEDICAL UNIVERSITY   (China)

^k THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^l Maternal and Child Health Hospital in Guangxi   (China)

^m 105th Hospital of People's Liberation Army   (China)

ⁿ CHINA MEDICAL UNIVERSITY   (China)

^o Qingdao Women and Children Medical Healthcare Center   (China)

^p WEIFANG MEDICAL UNIVERSITY   (China)

^q LINYI PEOPLE'S HOSPITAL   (China)

^r Shandong Jingning First People's Hospital   (China)

^s QINGDAO UNIVERSITY   (China)

^t YANTAI YUHUANGDING HOSPITAL   (China)

^u Jinan Health Institute of Maternity and Infant   (China)

^v FIRST MILITARY MEDICAL UNIVERSITY   (China)

^w JINING MEDICAL UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHINESE; CHROMOSOME 2; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOME; HUMAN; INTROSPECTION; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 2; CHROMOSOMES, HUMAN, PAIR 9; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; META-ANALYSIS AS TOPIC; ODDS RATIO; POLYCYSTIC OVARY SYNDROME;

EID: 78651256136     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.732     Document Type: Article

References (39)

1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil. Steril. 81, 19-25 (2004).
2. Goodarzi, M.O. & Azziz, R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 20, 193-205 (2006). (Pubitemid 43842923)
3. Ehrmann, D.A., Barnes, R.B., Rosenfeld, R.L., Cavaghan, M.K. & Imperial, J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 22, 141-146 (1999).
4. Carmina, E. Cardiovascular risk and events in polycystic ovary syndrome. Climacteric 12 (suppl. 1), 22-25 (2009).
5. Kandaraki, E., Christakou, C. & Diamanti-Kandarakis, E. Metabolic syndrome and polycystic ovary syndrome; and vice versa. Arq. Bras. Endocrinol. Metabol. 53, 227-237 (2009).
6. Wild, S., Pierpoint, T., Jacobs, H. & McKeigue, P. Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum. Fertil. (Camb.) 3, 101-105 (2000).
7. Espinós-Gómez, J.J., Corcoy, R. & Calaf, J. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome. Gynecol. Endocrinol. 25, 199-204 (2009).
8. Kulshreshtha, B. et al. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome. Gynecol. Endocrinol. 24, 637-643 (2008).
9. Shi, Y. et al. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Neuroendocrinol. Lett. 28, 807-810 (2007).
10. Sudo, S. et al. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol. Hum. Reprod. 8, 893-899 (2002).
11. Wang, Y., Wu, X., Cao, Y., Yi, L. & Chen, J. A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome. Fertil. Steril. 86, 223-226 (2006).
12. Chen, Z.J. et al. Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 39, 582-585 (2004).
13. Villuendas, G., San Millán, J.L., Sancho, J. & Escobar-Morreale, H.F. The -597 G→A and -174 G→C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism. J. Clin. Endocrinol. Metab. 87, 1134-1141 (2002).
14. Carlson, C.S., Eberle, M.A., Kruglyak, L. & Nickerson, D.A. Mapping complex disease loci in whole-genome association studies. Nature 429, 446-452 (2004).
15. Xu, S. et al. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am. J. Hum. Genet. 85, 762-774 (2009).
16. Price, A.L. et al. Principal components analysis corrects for stratifcation in genome-wide association studies. Nat. Genet. 38, 904-909 (2006).
17. Huang, M. et al. Involvement of ALF in human spermatogenesis and male infertility. Int. J. Mol. Med. 17, 599-604 (2006).
18. Latronico, A.C. et al. A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol. Endocrinol. 12, 442-450 (1998).
19. Toledo, S.P.A. et al. An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46, XX female. J. Clin. Endocrinol. Metab. 81, 3850-3854 (1996).
20. Latronico, A.C., Lins, T.S., Brito, V.N., Arnhold, I.J. & Mendonca, B.B. The effect of distinct activating mutations of the luteinizing hormone receptor gene on the pituitary-gonadal axis in both sexes. Clin. Endocrinol. 53, 609-613 (2000).
21. Valkenburg, O. et al. Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum. Reprod. 24, 2014-2022 (2009).
22. Tong, Y., Liao, W.X., Roy, A.C. & Ng, S.C. Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovarian failure and polycystic ovary syndrome. Horm. Metab. Res. 33, 221-226 (2001).
23. Du, J. et al. Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome. Mol. Genet. Metab. 100, 292-295 (2010).
24. Drieschner, N. et al. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin. Thyroid 16, 1091-1096 (2006).
25. Zeggini, E. et al. Meta-analysis of genome-wide association data and large-scale replication identifes additional susceptibility loci for type 2 diabetes. Nat. Genet. 40, 638-645 (2008).
26. Hu, C. et al. PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS ONE 4, e7643 (2009).
27. Del Villar, K. & Miller, C.A. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc. Natl. Acad. Sci. USA 101, 4210-4215 (2004).
28. Olszanecka-Glinianowicz, M. et al. Is the polycystic ovary syndrome associated with chronic infammation per se? Eur. J. Obstet. Gynecol. Reprod. Biol. 133, 197-202 (2007).
29. Ferriman, D. & Gallwey, J.D. Clinical assessment of body hair growth in women. J. Clin. Endocrinol. Metab. 21, 1440-1447 (1961).
30. Shi, Y., Gao, X., Sun, X., Zhang, P. & Chen, Z. Clinical and metabolic characteristics of polycystic ovary syndrome without polycystic ovary: a pilot study on Chinese women. Fertil. Steril. 90, 1139-1143 (2008).
31. Radziuk, J. Insulin sensitivity and its measurement: structural commonalities among the methods. J. Clin. Endocrinol. Metab. 85, 4426-4433 (2000).
32. Korn, J.M. et al. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat. Genet. 40, 1253-1260 (2008).
33. Thomas, G. et al. Capillary and microelectrophoretic separations of ligase detection reaction products produced from low-abundant point mutations in genomic DNA. Electrophoresis 25, 1668-1677 (2004).
34. Yi, P. et al. PCR/LDR/capillary electrophoresis for detection of single-nucleotide differences between fetal and maternal DNA in maternal plasma. Prenat. Diagn. 29, 217-222 (2009).
35. Shi, Y.Y. & He, L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 15, 97-98 (2005).
36. Petukhova, L. et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466, 113-117 (2010).
37. Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263 (2005).
38. Saxena, R. et al. Genome-wide association analysis identifes loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336 (2007).
39. Mantel, N. & Haenszel, W. Statistical aspects of the analysis of data from retrospective studies. J. Natl. Cancer Inst. 22, 719-748 (1959).